Key facts
- This page summarizes Camela Wisel's Form 4 filing for Chemours Co (CC).
- 1 reported transaction and 0 derivative rows are listed below.
- Accepted by SEC: 03 Aug 2023, 16:51.
Camela Wisel - 01 Aug 2023 Form 4 Insider Report for Chemours Co (CC)
- Reporting relationship
- VP, CAO & Controller
- Issuer ticker
- CC
- Reported as of
- 01 Aug 2023
- Net transaction value
- $0
- SEC form
- 4
- Accepted by SEC
- 03 Aug 2023, 16:51:48 UTC
- Prior SEC filing
- 10 Mar 2023
- Source filing
- View source filing
- Reporting owner signature
- /s/ Nicole Perez Lengel, Attorney-in-Fact
Source evidence
Original filing metadata and source links for verification.
4 source fields
Reporting owner
1 detail
Key filing fact
Camela Wisel filed Form 4 for Chemours Co (CC) on 03 Aug 2023.
Change
- Previous filing in this sequence was filed on 10 Mar 2023.
- Current net transaction value: $0.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
CC
transaction
Common Stock
Award
- Transaction value
- $0
- Shares
- +5,425
- Change %
- +46%
- Price
- $0.000000
- Shares after
- 17,144
- Date
- 01 Aug 2023
- Ownership
- Direct
- Footnotes
- F1, F2
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 2 footnotes
Footnote F1
Restricted Stock Unit (RSU) award scheduled to vest with respect to 100% of the RSUs, including dividend equivalent units, on August 1, 2026.
Footnote F2
Includes directly owned shares, stock units and dividend equivalent units.